18 September 2025
Novo Nordisk: Ozempic® Cuts Heart Attack, Stroke, and Death Risk by 23% vs. Dulaglutide
Ozempic® shows 26% lower death risk and 25% reduced risk of major cardiovascular events in older diabetes patients compared to dulaglutide in a real-world study.
